ArticleGenes & genomics2026
Ferroptosis modulation by Toxoplasma gondii suppresses sodium iodate-driven age-related macular degeneration.
Article in Genes & genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundOxidative stress is a central driver of retinal pigment epithelium (RPE) degeneration and a defining pathological feature of age-related macular degeneration (AMD). Sodium iodate (NaIO3) is widely used to model oxidative injury in RPE cells, yet the molecular checkpoints that determine whether oxidatively stressed RPE cells succumb or survive remain poorly defined.
objectiveThis study aimed to investigate whether Toxoplasma gondii (T. gondii) infection modulates NaIO3-induced oxidative stress and ferroptotic vulnerability in human RPE cells, and to elucidate the role of ferroptosis in RPE degeneration.
methodsARPE-19 cells were exposed to NaIO3 to induce oxidative stress and ferroptosis-associated injury, followed by infection with T. gondii. Cellular viability, cytosolic and mitochondrial reactive oxygen species (ROS), lipid peroxidation, iron homeostasis, and the expression of key ferroptosis-related regulators, including GPX4 and SLC7A11, were assessed using biochemical assays, fluorescence imaging, and immunoblotting.
resultsNaIO3 exposure impaired ferroptosis-associated antioxidant defenses in ARPE-19 cells by suppressing GPX4 and SLC7A11, disrupting iron homeostasis, and amplifying cytosolic and mitochondrial ROS production. T. gondii infection reversed this ferroptotic priming, markedly reduced oxidative stress, and protected RPE cells from lipid peroxidation–driven apoptotic execution. This parasite-driven cytoprotective conversion identifies ferroptosis as a pivotal regulatory node in host–pathogen interactions within the retina.
conclusionsOur findings demonstrate that T. gondii counteracts oxidative–ferroptotic stress to preserve RPE integrity, highlighting ferroptosis modulation as a key mechanism linking oxidative stress, retinal degeneration, and parasite-driven host cell reprogramming. These results expand the conceptual framework for understanding how host–pathogen interactions shape tissue vulnerability and survival in retinal disease contexts.
Indexed as
Identifiers
41855010What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.